Back to the main directory
EarningsReview / Equity
- Adding coverage of CCEP''s Amsterdam listing by BNP Paribas Exane
- FQ3''23 preview: out of favour, but out of hope? by BNP Paribas Exane
- Luk Fook (590 HK) by HSBC
- PatientSky Group (No_rec, TP: NOK) - Discontinuing coverage by DnB Markets
- Grieg Seafood (Buy, TP: NOK90.00) - Q2e consensus too high, but share-price upside potential now solid by DnB Markets
- Adevinta (Buy, TP: NOK120.00) - Growth set to continue by DnB Markets
- Carasent (Buy, TP: NOK32.00) - Limited estimate revisions by DnB Markets
- Borregaard (Buy, TP: NOK200.00) - BioSolutions improving gradually by DnB Markets
- Veidekke (Buy, TP: NOK125.00) - Solid balance sheet and DPS by DnB Markets
- Ncc (Buy, TP: SEK130.00) - EBIT-margin stability in focus by DnB Markets
- Tomra (Sell, TP: NOK140.00) - Multiples still appear too rich by DnB Markets
- Truecaller (Buy, TP: SEK48.00) - IPL pushing Truecaller to growth by DnB Markets
- A tale of cash flows and yields by DnB Markets
- A canary in the iron ore mine by BNP Paribas Exane
- Iron Ore Majors head-to-head: pivoting in a surplus market by BNP Paribas Exane
- Surprise progress on cross-holding structure by BNP Paribas Exane
- Entech - Résultats meilleurs que prévu by MidCap Partners
- INVEST SECURITIES - TME PHARMA : mOS : 5 patients sur 6 toujours en vie à 15 mois ! ACHAT, OC 4,2€ by Invest Securities
- Dustin - Hold: Weak demand, but in the right places by Nordea
- Sequana Medical - Additional POSEIDON data confirm benefits by Edison Investment Research
- F4Q23 Quick Take by BNP Paribas Exane
- Hongta Securities (601236 CH) by HSBC
- Tianfeng Securities (601162 CH) by HSBC
- First Capital Securities (002797 CH) by HSBC
- Mendus - Management update on vididencel in AML by Edison Investment Research
- Taiwan Petrochemicals by HSBC
- Medical Aesthetics by BNP Paribas Exane
- Verizon to hold steady, ATandT looking weak into 2Q by BNP Paribas Exane
- Sinch (Buy, TP: SEK70.00) - Poised for improved growth by DnB Markets
- Norwegian Air Shuttle (Buy, TP: NOK15.00) - Backlog momentum by DnB Markets
- Nolato (Buy, TP: SEK70.00) - Prescription for growth by DnB Markets
- Protector (Buy, TP: NOK213.00) - Set for UK growth spurt by DnB Markets
- Skanska (Buy, TP: SEK210.00) - Well positioned in a tough climate by DnB Markets
- AF Gruppen (Sell, TP: NOK100.00) - High order intake, but consensus and P/E valuation look too high by DnB Markets
- Peab (Hold, TP: SEK45.00) - Leverage likely the main risk by DnB Markets
- Yara (Buy, TP: NOK475.00) - Attractive on normalised earnings by DnB Markets
- June web-activity insights by DnB Markets
- Stolt-Nielsen - Let’s get chemical by Danske Bank Equity Research
- Pricing in the Pressures by BNP Paribas Exane
- China trip: the party line needs to pivot - can it? by BNP Paribas Exane
- UK Telcos: Consolidation relief or nightmare? by BNP Paribas Exane
- Entech - Stronger Than Expected Results by MidCap Partners
- INVEST SECURITIES - SCBSM : Un recentrage pertinent face à la crise, NEUTRE vs ACHAT, OC 9,2€ (vs 10,2€) by Invest Securities
- In the Driver''s Seat by BNP Paribas Exane
- On the Road with BNPP Exane by BNP Paribas Exane
- F4Q23 Prepared Remarks Notes by BNP Paribas Exane
- 红塔证券（601236 CH） by HSBC
- 天风证券（601162 CH） by HSBC
- 第一创业（002797 CH） by HSBC
- Nano Dimension - Revised tender offer for Stratasys by Edison Investment Research